Cybin Inc. Common Stock (HELP) Live Share Price, Invest From India

Cybin Inc. Common Stock Stock Performance

as on June 3, 2026 at 6:59 am IST

Day's Low
Day's High
$4.53
Day's Price Range
$4.75
$4.56
0.66%
Downside
4.17%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$4.56
100.00%
Downside
-100.00%
Upside

Cybin Inc. Common Stock share price movements today

Previous Close: $4.69
Open: $4.72
Volume: 795.9K
Day's Low - High: $4.53 - $4.75

Cybin Inc. Common Stock Historical Returns

1 Month Return: -8.93 %
3 Month Return: -38.37 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Cybin Inc. Common Stock Stock Fundamentals & Key Indicators

Check Cybin Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$227.0M

EPS (TTM)

-5.2372

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-55.89%

Cybin Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cybin Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Cybin Inc. Common Stock	NA	$227.0M	NA	NA	0.00%	NA
Revolution Medicines Inc	BUY	$33.5B	434.2%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$40.3B	106.95%	75.68	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$113.6B	108.38%	26.53	35.51%	NA
Regeneron Pharmaceuticals Inc	BUY	$64.5B	18.86%	15.02	29.65%	0.58%

Indian Investors' Interest in Cybin Inc. Common Stock Stock

Search interest for Cybin Inc. Common Stock Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 4, 2026 to June 3, 2026

Change:-14% versus previous 30 day period

Cybin Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	-	0	0	0
Operating Income	-57	-32	-33	-33	-40	-56
EBITDA	-57	-32	-	-33	-40	-56
Interest Expense	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0
Income Before Tax	-56	-10	-30	-33	-47	-58
Income Tax Expense	-	-	-	-	-	-
Net Income	-56	-7	-21	-33	-47	-58
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cybin Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Revenue	0	-	-	-	-
Gross Profit	0	0	0	0	0
Operating Income	-31	-63	-51	-78	-143
EBITDA	-30	-63	-51	-78	-142
Interest Expense	0	0	-	-	-
Depreciation	-	0	0	0	0
Income Before Tax	-32	-67	-47	-78	-113
Income Tax Expense	-	-	-	-	-
Net Income	-32	-53	-34	-57	-78
Net Profit Margin	-3729.17%	0.00%	0.00%	0.00%	0.00%

Cybin Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-30	-21	-10	-56	-10	-50	-24	-47	-58
Operating Cash Flow	-26	-20	-19	-25	-26	-21	-29	-48	-43
Investing Cash Flow	7	0	0	0	0	-	0	0	0
Financing Cash Flow	39	190	0	0	0	20	54	0	197
Change in Cash	20	169	-20	-26	-28	-1	24	-48	152

Cybin Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Mar 2019	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Income	0	-32	-67	-47	-78	-113
Operating Cash Flow	0	-19	-45	-47	-68	-101
Investing Cash Flow	0	-1	0	-3	6	-1
Financing Cash Flow	-	82	35	13	254	20
Change in Cash	0	62	-10	-37	192	-73

Global Institutional Holdings in Cybin Inc. Common Stock

Funds	Holdings
Sphera Funds Management Ltd.	1.98%
Nan Fung Group Holdings Ltd	0.92%
AdvisorShares Investments, LLC	0.39%
Millennium Management LLC	4.84%
Rosalind Advisors, Inc.	3.07%

See all

Insights on Cybin Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 540.1% return, outperforming this stock by 593.8%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 303.4% return, outperforming this stock by 347.0%
NEGATIVE IMPACT
Price Dip
In the last 3 months, HELP stock has moved down by -40.6%

About Cybin Inc. Common Stock

Cybin Inc., doing business as Helus Pharma, a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. It develops CYB003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and CYB004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company also develops SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat central nervous system, as well as has a research pipeline of investigational psychedelic-based compounds. It has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.

Organisation	Cybin Inc. Common Stock
Headquarters	100 King Street West, Toronto, ON, Canada, M5X 1C9
Industry	Biotechnology
CEO	Mr. Eric So L.L.B.
E-voting on shares	Click here to vote

Key Management of Cybin Inc. Common Stock

Name	Title
Mr. Eric So L.L.B.	Co-Founder, Interim CEO, President & Executive Chairman
Mr. Greg Cavers	Chief Financial Officer
Mr. George Tziras	Chief Business Officer
Mr. Paul Glavine	Co-Founder, Chief Growth Officer & Director
Mr. Gabriel Fahel	Chief Legal Officer & Corporate Secretary
Mr. John Kanakis	Co-Founder
Mr. Aaron Bartlone	Chief Operating Officer
Dr. Alex L. Nivorozhkin Ph.D.	Chief Scientific Officer
Ms. Lori Challenger	Chief Compliance, Ethics & Administrative Officer
Sara Brittany Somerset	Chief Communications Officers

FAQs

What is Cybin Inc. Common Stock share price today?

Cybin Inc. Common Stock share price today is $4.56 as on June 3, 2026 at 1:29 am IST at the close of the market. Cybin Inc. Common Stock share today touched a day high of $4.75 and a low of $4.53.

What is the 52 week high and 52 week low for Cybin Inc. Common Stock share?

Cybin Inc. Common Stock share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. Cybin Inc. Common Stock stock price today i.e. June 3, 2026 at 1:29 am IST is closed at $4.56,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Cybin Inc. Common Stock's market capitalisation today?

Cybin Inc. Common Stock market capitalisation is $0.00T as on June 3, 2026 at 1:29 am IST.

How to invest in Cybin Inc. Common Stock Stock (HELP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cybin Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cybin Inc. Common Stock Shares that will get you 0.3289 shares as per Cybin Inc. Common Stock share price of $4.56 per share as on June 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cybin Inc. Common Stock Stock (HELP) from India?

Indian investors can start investing in Cybin Inc. Common Stock (HELP) shares with as little as ₹95.265 or $1 (as of June 3, 2026 at 6:05 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.65 in Cybin Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on June 3, 2026 at 6:05 am IST). Based on Cybin Inc. Common Stock share’s latest price of $4.56 as on June 3, 2026 at 1:29 am IST, you will get 2.1930 shares of Cybin Inc. Common Stock. Learn more about fractional shares .